For example, the modulation of gut microbiota, e.g. dietary intervention with oligofructoses, reduced metabolic endotoxemia and the cecal content of LPS, improved glucose intolerance, insulin sensitivity and decreased body weight gain in both high-fat fed and ob/ob mice [78]. The gene discussed is INS; the disease is Glucose intolerance.